At a glance
- Originator Schering-Plough
- Class Antihypertensives
- Mechanism of Action Adenosine A1 receptor agonists; Adenosine A2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 22 Feb 2000 No-Development-Reported for Hypertension in Italy (PO)
- 25 Mar 1997 New profile
- 25 Mar 1997 Preclinical development for Hypertension in Italy (PO)